A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
The “2023 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Novaliq, of Heidelberg, Germany, reported June 8 that the US FDA had approved Vevye (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. June 8 wa...
Israel-based CorNeat Vision reported June 8 that the US FDA had cleared itsEverPatch scleral reinforcement patch. The graft is the first synthetic, nondegradable tissue-integrating matrix for use i...
South Korea-based HanAll Biopharma reported May 19 that its topical anti-inflammatory dry eye candidate tanfanercept missed its primary endpoints in the Phase III VELOS-3 trial. Tanfanercept did no...
Merck on June 6 sued the US Department ofHealth and Human Services (HHS) over Medicare’s plans to reduce drug prices under the Inflation Reduction Act of 2022, calling the price negotiation process...
Researchers at Johns Hopkins’ Wilmer Eye Institute reported May 24 that they and colleagues from the University of Maryland had used machine learning—a method employed to create artificial intellig...
Sightpath Medical, of Bloomington, Minnesota, announced June 5 that it would integrate Southern Surgical Support, a Knoxville, Tennessee, mobile cataract services company, into its business. The mo...
Israel’s BioLight Life Sciences and Alexion announced May 30 that they would collaborate on a study of new technology that has the potential to screen the tear film to diagnose retinal disease. The...
Vyluma announced June 6 that the US FDA had accepted its new drug application (NDA) for lead compound NVK002 (low dose atropine 0.01%) for childhood myopia and set a Prescription Drug User Fee Act ...
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayA Multi-Step Approach for Accurate & Timely Data
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.